Ticker: BMRN

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has reported significant financial developments in its latest quarterly earnings for the period ending June 30, 2025. The company, dedicated to the development of therapies for rare genetic disorders, continues to show a robust financial performance alt...